Illumina to Divest Cancer-Test Maker Grail If It Loses Final Appeals in US, EU
Illumina to Divest Cancer-Test Maker Grail If It Loses Final Appeals in US, EU
如果Illumina在美國、歐盟的最終上訴敗訴，它將剝離癌症測試製造商Grail
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間